Abbott

Abbott is listed as a company in Pharma & Medical Devices. It has filed 3 comment letters on 3 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type: Company
Industry: Pharma & Medical Devices
Comment letters: 3
Rules commented on: 3
First letter: 2025-09-12
Latest letter: 2026-09-16
Agencies most often: Centers for Medicare & Medicaid Services (3)

Activity by year

20251

20262

Letters

2026

Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies

CMS-2026-2311Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-16

Read the letter ↗

Request for Information; Clinical Laboratory Improvement Amendments of 1988 (CLIA) Regulations

CMS-2026-2345Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-15

Read the letter ↗

2025

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction

CMS-2025-0304Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-09-12

Read the letter ↗